Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKinsey
UBS
Baxter
AstraZeneca
Cantor Fitzgerald
Medtronic
Chubb
Cipla

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021604

« Back to Dashboard

NDA 021604 describes CHILDREN'S ELIXSURE, which is a drug marketed by Moberg Pharma North and is included in one NDA. Additional details are available on the CHILDREN'S ELIXSURE profile page.

The generic ingredient in CHILDREN'S ELIXSURE is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-six suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 021604
Tradename:CHILDREN'S ELIXSURE
Applicant:Moberg Pharma North
Ingredient:ibuprofen
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SUSPENSION;ORALStrength100MG/5ML
Approval Date:Jan 7, 2004TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Express Scripts
Boehringer Ingelheim
Harvard Business School
Argus Health
US Department of Justice
McKesson
Accenture
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.